MNKD Competitors & Alternatives
Compare MannKind Corp with similar stocks in the same industry
Biotechnology
MNKD
Main Stock$4.19
Tradestie Score
37
Market Cap
$1.65B
Revenue Growth
0.2%
Analyst Upside
+98.9%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$31.80
|
$1.49B | - | 43 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$18.80
|
$1.43B | - | 63 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$12.39
|
$1.42B | - | 51 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.59
|
$1.35B | - | 60 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$27.02
|
$1.32B | - | 45 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.52
|
$1.29B | - | 39 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$27.76
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.13
|
$1.29B | - | 65 | Compare |
|
ZYME
Zymeworks Inc.
|
$29.07
|
$1.28B | 59.4 | 42 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.29
|
$1.27B | - | 57 | Compare |
More MNKD Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry